Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 6
2012 17
2013 22
2014 42
2015 72
2016 70
2017 75
2018 73
2019 86
2020 75
2021 71
Text availability
Article attribute
Article type
Publication date

Search Results

518 results
Results by year
Filters applied: . Clear all
Page 1
Vortioxetine: Clinical Pharmacokinetics and Drug Interactions.
Chen G, Højer AM, Areberg J, Nomikos G. Chen G, et al. Clin Pharmacokinet. 2018 Jun;57(6):673-686. doi: 10.1007/s40262-017-0612-7. Clin Pharmacokinet. 2018. PMID: 29189941 Free PMC article. Review.
Vortioxetine is orally administered once daily at 5- to 20-mg doses. ...The mean absolute oral bioavailability of vortioxetine is 75%. No food effect on pharmacokinetics was observed. ...
Vortioxetine is orally administered once daily at 5- to 20-mg doses. ...The mean absolute oral bioavailability of vortioxetine
Vortioxetine Treatment for Anxiety Disorder: A Meta-Analysis Study.
Yee A, Ng CG, Seng LH. Yee A, et al. Curr Drug Targets. 2018;19(12):1412-1423. doi: 10.2174/1389450118666171117131151. Curr Drug Targets. 2018. PMID: 29149828 Review.
The aim of this review is to quantitatively synthesize all data of the efficacy, safety and tolerability of Vortioxetine in treating anxiety disorder. METHOD: Terms of "Vortioxetine" OR "LuAA21004" AND "anxiety" OR "fear" OR "panic" OR "phobia" were searched. ...Mos …
The aim of this review is to quantitatively synthesize all data of the efficacy, safety and tolerability of Vortioxetine in treating …
Vortioxetine: a novel antidepressant for the treatment of major depressive disorder.
Gonda X, Sharma SR, Tarazi FI. Gonda X, et al. Expert Opin Drug Discov. 2019 Jan;14(1):81-89. doi: 10.1080/17460441.2019.1546691. Epub 2018 Nov 20. Expert Opin Drug Discov. 2019. PMID: 30457395 Review.
Vortioxetine is a novel antidepressant drug approved for the treatment of major depressive disorder (MDD) in adults. ...Expert opinion: Vortioxetine displays high affinity for serotonin transporter (SERT), and serotonin 5-HT(3), 5HT(1A), 5HT(7) receptors. ...
Vortioxetine is a novel antidepressant drug approved for the treatment of major depressive disorder (MDD) in adults. ...Expert opinio
Vortioxetine for depression in adults.
Koesters M, Ostuzzi G, Guaiana G, Breilmann J, Barbui C. Koesters M, et al. Cochrane Database Syst Rev. 2017 Jul 5;7(7):CD011520. doi: 10.1002/14651858.CD011520.pub2. Cochrane Database Syst Rev. 2017. PMID: 28677828 Free PMC article. Review.
Seven studies were placebo controlled; eight studies compared vortioxetine to serotonin-norepinephrine reuptake inhibitors (SNRIs). ...Furthermore, the quality of evidence to support these findings was generally low. In comparison to SNRIs, we found no advantage for vor
Seven studies were placebo controlled; eight studies compared vortioxetine to serotonin-norepinephrine reuptake inhibitors (SNRIs). . …
Vortioxetine: A new alternative for the treatment of major depressive disorder.
Salagre E, Grande I, Solé B, Sanchez-Moreno J, Vieta E. Salagre E, et al. Rev Psiquiatr Salud Ment (Engl Ed). 2018 Jan-Mar;11(1):48-59. doi: 10.1016/j.rpsm.2017.06.006. Epub 2017 Aug 8. Rev Psiquiatr Salud Ment (Engl Ed). 2018. PMID: 28800937 Review. English, Spanish.
Major Depressive Disorder (MDD) is a serious psychiatric condition. Its treatment remains a challenge nowadays. Vortioxetine is a novel antidepressant with a unique profile, as it acts as a multimodal serotoninergic agent. ...The aim of this systematic review is to describ …
Major Depressive Disorder (MDD) is a serious psychiatric condition. Its treatment remains a challenge nowadays. Vortioxetine is a nov …
Vortioxetine: A Review in Cognitive Dysfunction in Depression.
Frampton JE. Frampton JE. Drugs. 2016 Nov;76(17):1675-1682. doi: 10.1007/s40265-016-0655-3. Drugs. 2016. PMID: 27807822 Review.
In general, the beneficial effects of vortioxetine on these measures were largely independent of its effect on improving depressive symptoms. Based on the available data, therefore, vortioxetine is a useful treatment option in patients with MDD where impaired cognit …
In general, the beneficial effects of vortioxetine on these measures were largely independent of its effect on improving depressive s …
Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data.
Sanchez C, Asin KE, Artigas F. Sanchez C, et al. Pharmacol Ther. 2015 Jan;145:43-57. doi: 10.1016/j.pharmthera.2014.07.001. Epub 2014 Jul 9. Pharmacol Ther. 2015. PMID: 25016186 Free article. Review.
Vortioxetine, a novel antidepressant for the treatment of major depressive disorder (MDD), is a 5-HT3, 5-HT7 and 5-HT1D receptor antagonist, 5-HT1B receptor partial agonist, 5-HT1A receptor agonist and serotonin (5-HT) transporter (SERT) inhibitor. ...In two positive studi
Vortioxetine, a novel antidepressant for the treatment of major depressive disorder (MDD), is a 5-HT3, 5-HT7 and 5-HT1D receptor anta
Vortioxetine.
[No authors listed] [No authors listed] Aust Prescr. 2015 Jun;38(3):101-2. doi: 10.18773/austprescr.2015.037. Epub 2015 Mar 23. Aust Prescr. 2015. PMID: 26648632 Free PMC article. Review. No abstract available.
Vortioxetine for Cognitive Enhancement in Major Depression: From Animal Models to Clinical Research.
Bennabi D, Haffen E, Van Waes V. Bennabi D, et al. Front Psychiatry. 2019 Nov 6;10:771. doi: 10.3389/fpsyt.2019.00771. eCollection 2019. Front Psychiatry. 2019. PMID: 31780961 Free PMC article. Review.
Methods: We conducted a review of key data obtained from preclinical behavioral models and clinical trials in MDD focusing on vortioxetine-induced cognitive changes. Results: In animals, acute and chronic administration of vortioxetine improves performance on object …
Methods: We conducted a review of key data obtained from preclinical behavioral models and clinical trials in MDD focusing on vortioxetin
Vortioxetine for Depression in Adults.
Long JD. Long JD. Issues Ment Health Nurs. 2019 Sep;40(9):819-820. doi: 10.1080/01612840.2019.1604920. Epub 2019 Jun 21. Issues Ment Health Nurs. 2019. PMID: 31225773 Review. No abstract available.
518 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page